Page 9 - Remunity Pump News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Russell Investments Group Ltd. lessened its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 12.4% in the second quarter, HoldingsChannel.com reports. The firm owned 116,338 shares of the biotechnology company’s stock after selling 16,450 shares during the period. Russell Investments Group Ltd.’s holdings in United Therapeutics were worth $25,682,000 as of […]

Rhumbline Advisers raised its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 5.2% during the second quarter, Holdings Channel.com reports. The firm owned 140,779 shares of the biotechnology company’s stock after purchasing an additional 6,997 shares during the quarter. Rhumbline Advisers’ holdings in United Therapeutics were worth $31,077,000 as of its most recent […]

United Therapeutics (NASDAQ:UTHR – Get Free Report) was upgraded by equities researchers at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Thursday. Several other equities analysts also recently commented on UTHR. Morgan Stanley increased their target price on United Therapeutics from $316.00 to $318.00 and gave the […]

Operator: Good morning, and welcome to the United Therapeutics Corporation Third Quarter 2023 Earnings Webcast. My name is Rocco, and I will be your conference operator today.

United Therapeutics (NASDAQ:UTHR – Get Free Report) will be announcing its 09/30/2023 earnings results before the market opens on Wednesday, November 1st. Analysts expect the company to announce earnings of $4.88 per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link. United Therapeutics (NASDAQ:UTHR – […]